E-LIB Suche - Ergebnisse für: Klimek, Justin - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Syntheses, Characterization, and Redox Activity of Ferrocen..:

Schwitalla, Kevin ; Klimek, Justin ; Greven, Tobias..
ACS Omega. 9 (2024) 26 - p. 29017-29024 , 2024

Link: https://doi.org/10.1021/..

2

Protein biomarkers for response to XPO1 inhibition in haema..:

Totiger, Tulasigeri M. ; Chaudhry, Sana ; Musi, Elgilda...
Journal of Cellular and Molecular Medicine. 27 (2023) 4 - p. 587-590 , 2023

Link: https://doi.org/10.1111/..

3

Phase I First-in-Human Dose Escalation Study of the oral SF..:

Steensma, David P. ; Wermke, Martin ; Klimek, Virginia M....
Leukemia. 35 (2021) 12 - p. 3542-3550 , 2021

Link: https://doi.org/10.1038/..

4

Protein biomarkers for response to XPO1 inhibition in haema..:

Totiger, Tulasigeri M ; Chaudhry, Sana ; Musi, Elgilda...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930413/. , 2023

Link: http://www.ncbi.nlm.nih...

5

Robust patient-derived xenografts of MDS/MPN overlap syndro..:

Yoshimi, Akihide ; Balasis, Maria E ; Vedder, Alexis...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533204/. , 2017

Link: http://www.ncbi.nlm.nih...

6

PARP1 is required for chromosomal translocations:

Wray, Justin ; Williamson, Elizabeth A ; Singh, Sudha B...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2013

Link: http://www.ncbi.nlm.nih...

7

Phase I First-in-Human Dose Escalation Study of the oral SF..:

Steensma, David P ; Wermke, Martin ; Klimek, Virginia M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632688/. , 2021

Link: http://www.ncbi.nlm.nih...

8

A Phase II Study of Selinexor, a First-in-Class XPO1 Inhibi..:

Taylor, Justin ; Mi, Xiaoli ; Penson, Alexander V...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209897/. , 2020

Link: http://www.ncbi.nlm.nih...

9

CAG repeat expansion in Huntington disease determines age a..:

Lee, J.-M ; Ramos, E.M ; Lee, J.-H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306163. , 2012

Link: http://www.ncbi.nlm.nih...

1-9